Kobayashi Pharma stock sits 0.77 percent below its 52-week high
Published on 10/15/2026 at 18:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMarket position and upcoming date
- Kobayashi Pharma stood 0.77 percent below its 52-week high on October 15, 2026.
- An eight-analyst consensus target was JPY 5,521.30 on October 3, 2026.
- Kobayashi Pharma stock costs EUR 41.40 at Lang & Schwarz on October 15, 2026 at 6:34 p.m. CEST.
- The next earnings report is scheduled for November 10, 2026.
Kobayashi Pharma stock stood 0.77 percent below its 52-week high of JPY 7,377.00 on October 15, 2026. An eight-analyst consensus target of JPY 5,521.30 dated October 3, 2026 was 24.57 percent below the Tokyo price, according to Investing.com. The stock was at EUR 41.40 at Lang & Schwarz on October 15, 2026 at 6:34 p.m. CEST.
Target distance stays negative
The consensus target leaves a wide gap below the latest Tokyo quotation. The target is based on eight analysts and carries a neutral overall view, with two buy ratings, four hold ratings and two sell ratings, according to Investing.com. That distance matters because the shares are trading near the upper end of their yearly range.
Stock sits near yearly high
The Tokyo quotation was JPY 7,320.00 on October 15, 2026, while the day's range ran from JPY 7,251.00 to JPY 7,377.00. The 52-week range was JPY 5,030.00 to JPY 7,377.00, putting the latest price 45.53 percent above the low and 0.77 percent below the high. Trading volume reached 581,900 shares against an average of 270,927 shares.
Valuation and next date
Kobayashi Pharma had a market capitalization of JPY 544.2 billion and a price-to-earnings ratio of 334.71 on October 15, 2026. Its next earnings report is scheduled for November 10, 2026, according to Investing.com. The latest reported interim release covered the six months ended June 30, 2026 and was published on August 6, 2026, according to 6ix.
Comparison with peers
Kobayashi Pharma (Tokyo, JPY): price-to-earnings ratio 334.71, market capitalization JPY 544.2 billion
Shiseido (Tokyo, JPY): plus 1.07 percent, price-to-earnings ratio minus 66.31, market capitalization JPY 1.4 trillion
Kao (Tokyo, JPY): plus 1.64 percent, price-to-earnings ratio 24.95, market capitalization JPY 3.4 trillion
Price remains near the upper range
Kobayashi Pharma was trading at EUR 41.40 at Lang & Schwarz on October 15, 2026 at 6:34 p.m. CEST. Its Japanese listing was last at JPY 7,320.00 on October 15, 2026 at 3:30 p.m. JST.
The further course of trading is shown by the continuously updated real-time quote of Kobayashi Pharma stock.
Kobayashi Pharma market data
- Company: Kobayashi Pharmaceutical Co., Ltd.
- ISIN: JP3301100008
- Ticker: 4967
- Primary exchange: Tokyo Stock Exchange
- Price Lang & Schwarz (as of October 15, 2026, 6:34 p.m. CEST): EUR 41.40
- Market capitalization: JPY 544.2 billion (as of October 15, 2026)
- 52-week range: JPY 5,030.00-7,377.00 (as of October 15, 2026)
- Sector / Industry: Consumer Non-Cyclicals / Personal and Household Products and Services
Market context: Market report Nikkei 225.
